DHR and NBT - CGD Screening, EDTA Blood
₹ 7,000
DHR and NBT - CGD Screening, EDTA Blood
At Health Avenue Path Labs, we understand the importance of early and accurate diagnosis. The DHR and NBT - CGD Screening, EDTA Blood test is a specialized diagnostic tool designed to screen for Chronic Granulomatous Disease (CGD), a rare immune system disorder. This test is essential for identifying functional abnormalities in white blood cells, ensuring timely intervention and better management of the condition.
Why Choose This Test?
The DHR (Dihydrorhodamine) and NBT (Nitroblue Tetrazolium) test is a gold standard for CGD screening. Here's why this test is a critical addition to your health journey:
- High Accuracy: Combines two advanced methodologies to deliver precise results.
- Early Detection: Helps identify CGD early, aiding in prompt medical care.
- Specialized Testing: Conducted using EDTA blood for reliable and consistent outcomes.
- Expert Analysis: All samples are processed by experienced professionals at Health Avenue Path Labs.
Who Should Consider This Test?
This test is especially relevant for individuals experiencing recurrent infections, unexplained immune deficiencies, or those with a family history of CGD. It is also a valuable tool for healthcare providers in diagnosing and managing immune-related disorders.
Take Charge of Your Health Today!
Don't leave your health to chance. Trust Health Avenue Path Labs for accurate and timely diagnostics. Order the DHR and NBT - CGD Screening, EDTA Blood test today and take the first step towards a healthier future. Schedule your test now and gain peace of mind.